The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb (I)
Efficacy and safety results from the COMMANDS trial: A phase 3 study evaluating luspatercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naive transfusion-dependent (TD) patients (pts) with lower-risk myelodysplastic syndromes (LR-MDS).
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb/Celgene; Curis; Genentech; Gilead Sciences; Novartis
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb
Research Funding - Abbvie; Aprea Therapeutics; Astex Pharmaceuticals; Bristol-Myers Squibb; Curis; Genentech; Gilead Sciences; Novartis
 
Uwe Platzbecker
Honoraria - Abbvie; Celgene/Jazz; Curis; Geron; Janssen
Consulting or Advisory Role - BMS GmbH & Co. KG; Celgene/Jazz; Novartis
Research Funding - Amgen (Inst); BerGenBio (Inst); Celgene (Inst); Curis (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - part of a patent for a TFR-2 antibody (Rauner et al. Nature Metabolics 2019)
Travel, Accommodations, Expenses - Celgene
 
Valeria Santini
Honoraria - Celgene/Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Abbvie; Celgene/Bristol-Myers Squibb; Geron; Gilead Sciences; Menarini; Novartis; SERVIER; Syros Pharmaceuticals
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen-Cilag
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; Epizyme; Geron; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Epizyme; Geron; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Pierre Fenaux
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Rami S. Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Geron; Gilead/Forty Seven; Jazz Pharmaceuticals; Novartis; Pharmaessentia; Taiho Oncology; Takeda
Speakers' Bureau - Abbvie; CTI BioPharma Corp; Jazz Pharmaceuticals; Pharmaessentia; SERVIER
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Jazz Pharmaceuticals; Pharmaessentia
 
Jake Shortt
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Mundipharma; Novartis; Otsuka; Pfizer
Speakers' Bureau - Mundipharma
Research Funding - Amgen; Astex Pharmaceuticals
 
David Valcarcel
Consulting or Advisory Role - Amgen; BMS; Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; NOVARTIS; Pfizer; Sanofi; SOBI; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; BMS; Celgene; Gebro Pharma; GlaxoSmithKline; Jazz Pharmaceuticals; Kite, a Gilead company; Novartis; Pfizer; Sanofi/Aventis
Travel, Accommodations, Expenses - Amgen; Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; Pfizer
 
Anna Jonasova
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Novartis
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb/Celgene
 
Sophie Dimicoli-Salazar
No Relationships to Disclose
 
Ing Soo Tiong
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Pfizer
 
Chien-Chin Lin
No Relationships to Disclose
 
Jiahui Li
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Sandra Kreitz
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
 
Veronika Pozharskaya
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Merck
 
Jeevan K. Shetty
No Relationships to Disclose
 
Andrius Degulys
Stock and Other Ownership Interests - Teladoc
Honoraria - Novartis; Sanofi; Takeda
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis; Sanofi; Takeda
Travel, Accommodations, Expenses - Abbvie; Novartis; Sanofi; Takeda
 
Carlo Finelli
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Novartis; Takeda
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Celgene/Bristol-Myers Squibb
 
Thomas Cluzeau
Honoraria - Celgene/Bristol-Myers Squibb; Novartis; SERVIER; Syros Pharmaceuticals; Takeda
Consulting or Advisory Role - Abbvie; Celgene/Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis; SERVIER
Speakers' Bureau - Astellas Pharma; Celgene/Bristol-Myers Squibb; Kite/Gilead; Novartis; SERVIER
Travel, Accommodations, Expenses - Abbvie; Celgene/Bristol-Myers Squibb; Novartis; Pfizer
 
Matteo Giovanni Della Porta
No Relationships to Disclose